LJI308 is primarily utilized in the field of cancer research, particularly in the study and treatment of various types of cancers. It functions as an inhibitor targeting specific proteins involved in cancer cell growth and survival. Researchers employ LJI308 to investigate its potential in disrupting signaling pathways that are crucial for tumor progression. This compound is often used in preclinical studies to evaluate its efficacy in reducing tumor size and inhibiting metastasis. Additionally, LJI308 is explored for its ability to enhance the effectiveness of other anticancer therapies when used in combination treatments. Its application extends to the development of novel therapeutic strategies aimed at improving outcomes for cancer patients.